{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:48:45Z","timestamp":1759333725105,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jaad.2021.06.888","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T23:51:28Z","timestamp":1626220288000},"page":"e291-e292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response to letter by Payal M. Patel and Kyle T. Amber on \u201cPemphigus management guidelines: A life-saving perspective\u201d"],"prefix":"10.1016","volume":"85","author":[{"given":"Saadia","family":"Tabassum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atiya","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nosheen","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaad.2021.06.888_bib1","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.chest.2020.05.558","article-title":"Risk factors and prevention of Pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases","volume":"158","author":"Ghembaza","year":"2020","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jaad.2021.06.888_bib2","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.chest.2020.07.011","article-title":"Response","volume":"158","author":"Ghembaza","year":"2020","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.jaad.2021.06.888_bib3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/jamadermatol.2017.2808","article-title":"Determining the incidence of pneumocystis pneumonia in patients with autoimmune blistering diseases not receiving routine prophylaxis","volume":"153","author":"Amber","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.06.888_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/bmt.2015.316","article-title":"The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis","volume":"51","author":"Williams","year":"2016","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"10.1016\/j.jaad.2021.06.888_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/rheumatology\/keaa436","article-title":"for the CARRA JDM Workgroup and the Childhood Myositis Heterogeneity Study Group. Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America","volume":"60","author":"Sabbagh","year":"2021","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221020995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221020995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:58:41Z","timestamp":1759273121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221020995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0190962221020995"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.06.888","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to letter by Payal M. Patel and Kyle T. Amber on \u201cPemphigus management guidelines: A life-saving perspective\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.06.888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.04.106","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}